Cited by

• The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2.

  Huang H, Zhang C, Yang S, Xiao W, Zheng Q, Song X. Huang H, et al. J Control Release. 2021 Jul 10;335:449-456. doi: 10.1016/j.jconrel.2021.05.024. Epub 2021 May 21. J Control Release. 2021. PMID: 34029632 Free PMC article.
• Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation.

  Schijns V, Majhen D, van der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-Tejada A, Alvarez-Dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, McClean S. Schijns V, et al. Pharmaceutics. 2021 Apr 6;13(4):501. doi: 10.3390/pharmaceutics13040501. Pharmaceutics. 2021. PMID: 33917629 Free PMC article. Review.
• Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients.

  Xin S, Chen W, Yu Q, Gao L, Lu G. Xin S, et al. Front Public Health. 2024 Jan 8;11:1330106. doi: 10.3389/fpubh.2023.1330106. eCollection 2023. Front Public Health. 2024. PMID: 38259762 Free PMC article.
• Safety pharmacology of human endogenous retrovirus-enveloped baculoviral DNA vaccines against SARS-CoV-2 in Sprague-Dawley rats and beagle dogs.

  Park SJ, Seo JW, Han KH, Lee BS, Lee C, Kim BY, Ko KC, Kim YB. Park SJ, et al. Vaccine X. 2024 Aug 3;20:100545. doi: 10.1016/j.jvacx.2024.100545. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39221182 Free PMC article.
• Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination.

  Wilkins D, Aksyuk AA, Ruzin A, Tuffy KM, Green T, Greway R, Fikes B, Bonhomme CJ, Esser MT, Kelly EJ. Wilkins D, et al. Clin Transl Immunology. 2022 Apr 26;11(4):e1385. doi: 10.1002/cti2.1385. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35495877 Free PMC article.